Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides—Harmonized Terminology and Tactical Recommendations
Shankar, G., Arkin, S., Cocea, L., Devanarayan, V., Kirshner, S., Kromminga, A., Quarmby, V., Richards, S., Schneider, C. K., Subramanyam, M., Swanson, S., Verthelyi, D., Yim, S.
Published in The AAPS journal (01.07.2014)
Published in The AAPS journal (01.07.2014)
Get full text
Journal Article
A first‐in‐human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of PF‐06741086, an anti‐tissue factor pathway inhibitor mAb, in healthy volunteers
Cardinal, M., Kantaridis, C., Zhu, T., Sun, P., Pittman, D. D., Murphy, J. E., Arkin, S.
Published in Journal of thrombosis and haemostasis (01.09.2018)
Published in Journal of thrombosis and haemostasis (01.09.2018)
Get full text
Journal Article
Phase 1 dose‐escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXaI16L)
Parsons‐Rich, D., Hua, F., Li, G., Kantaridis, C., Pittman, D. D., Arkin, S.
Published in Journal of thrombosis and haemostasis (01.05.2017)
Published in Journal of thrombosis and haemostasis (01.05.2017)
Get full text
Journal Article
Constraints on microbial metabolism drive evolutionary diversification in homogeneous environments
GUDELJ, I., BEARDMORE, R. E., ARKIN, S. S., MACLEAN, R. C.
Published in Journal of evolutionary biology (01.09.2007)
Published in Journal of evolutionary biology (01.09.2007)
Get full text
Journal Article
Phase 1, single‐dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia
Gruppo, R. A., Malan, D., Kapocsi, J., Nemes, L., Hay, C. R. M., Boggio, L., Chowdary, P., Tagariello, G., Drygalski, A., Hua, F., Scaramozza, M., Arkin, S., Hermans, C. R. J. R., Claes, C., Hanes, I., Huyghe, I., Kantaridis, C., Costa, L. M., Ndongo, M.‐N., Petit, W., Santagostino, E. M., Cannavo, A., Fasulo, M. R., Mancuso, M. E., Tosetto, A., Castaman, G., Candiotto, L., Radossi, P., Scarpa, E., Smith, M. P., Dick, A. E., Robson, R. A., Waaka, D. S., Wynne, C. J., Punt, Z. E., Kavakli, K. R., Balkan, C., Duyu, M., Goksel, S., Karapinar, B., Ozyurek, A. R., Saydam, G., Karapinar, D. Y., Laffan, M., Millar, C. M., Suppiah, P. I., Rizleigh, C. K., Chowdary, G. P., Davies, J. S., Fosbury, E. L., Gill, S., Pike, G. N., Varghese Thachil, J., Recht, M., Deutsche, J., Taylor, J., Kalinyak, K. A., Mullins, E. S., Palumbo, J. S., Quinn, C. T., Tarango, C., Tarabar, S., Chandler, P. A., Deats, L., Deshpande, S. R., Epstein, N. U., Hansson, A. G., Pawlak, S. S., Rudin, D., Valentino, L. A. J., Kakodkar, N. C., Simpson, M. L., Fogarty, P. F., Bach, Tami L., Chiang, Elaine Y., Adamson, J. W., Glass, C. S., Sidhu, N., Tucker‐Greene, T. D.
Published in Journal of thrombosis and haemostasis (01.10.2018)
Published in Journal of thrombosis and haemostasis (01.10.2018)
Get full text
Journal Article
Evolution of Future Black Sea Fish Stocks under Changing Environmental and Climatic Conditions
Salihoglu, Baris, Arkin, Sinan S., Akoglu, Ekin, Fach, Bettina A.
Published in Frontiers in Marine Science (21.11.2017)
Published in Frontiers in Marine Science (21.11.2017)
Get full text
Journal Article
Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII
RECHT, M., NEMES, L., MATYSIAK, M., MANCO-JOHNSON, M., LUSHER, J., SMITH, M., MANNUCCI, P., HAY, C., ABSHIRE, T., O'BRIEN, A., HAYWARD, B., UDATA, C., ROTH, D.A., ARKIN, S.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.07.2009)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.07.2009)
Get full text
Journal Article
BDDrFVIII (Moroctocog alfa [AF-CC]) for surgical haemostasis in patients with haemophilia A: results of a pivotal study
WINDYGA, J., RUSEN, L., GRUPPO, R., O'BRIEN, A. C., KELLY, P., ROTH, D. A, ARKIN, S.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2010)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2010)
Get full text
Journal Article
Human recombinant DNA‐derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation
Lusher, J., Abildgaard, C., Arkin, S., Mannucci, P. M., Zimmermann, R., Schwartz, L., Hurst, D.
Published in Journal of thrombosis and haemostasis (01.04.2004)
Published in Journal of thrombosis and haemostasis (01.04.2004)
Get full text
Journal Article
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study
Kessler, C. M., Gill, J. C., White II, G. C., Shapiro, A., Arkin, S., Roth, D. A., Meng, X., Lusher, J. M.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.03.2005)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.03.2005)
Get full text
Journal Article
Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review
KRAUT, E. H., ALEDORT, L. M., ARKIN, S., STINE, K. C., WONG, W.-Y.
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2007)
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01.09.2007)
Get full text
Journal Article
Understanding the limits to generalizability of experimental evolutionary models
Forde, Samantha E., Beardmore, Robert E., Gudelj, Ivana, Arkin, Sinan S., Thompson, John N., Hurst, Laurence D.
Published in Nature (11.09.2008)
Published in Nature (11.09.2008)
Get full text
Journal Article
Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors
Arkin, S, Blei, F, Fetten, J, Foulke, R, Gilchrist, G S, Heisel, M A, Key, N, Kisker, C T, Kitchen, C, Shafer, F E, Shah, P C, Strickland, D
Published in Blood coagulation & fibrinolysis (01.04.2000)
Get more information
Published in Blood coagulation & fibrinolysis (01.04.2000)
Journal Article